These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 22507334)

  • 1. Neuroprotective and anti-inflammatory activities of atorvastatin in a rat chronic constriction injury model.
    Chu LW; Chen JY; Yu KL; Cheng KI; Wu PC; Wu BN
    Int J Immunopathol Pharmacol; 2012; 25(1):219-30. PubMed ID: 22507334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atorvastatin prevents neuroinflammation in chronic constriction injury rats through nuclear NFκB downregulation in the dorsal root ganglion and spinal cord.
    Chu LW; Chen JY; Wu PC; Wu BN
    ACS Chem Neurosci; 2015 Jun; 6(6):889-98. PubMed ID: 25874913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HMG-CoA reductase inhibitor, atorvastatin, promotes sensorimotor recovery, suppressing acute inflammatory reaction after experimental intracerebral hemorrhage.
    Jung KH; Chu K; Jeong SW; Han SY; Lee ST; Kim JY; Kim M; Roh JK
    Stroke; 2004 Jul; 35(7):1744-9. PubMed ID: 15166393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atorvastatin attenuates neuropathic pain in rat neuropathy model by down-regulating oxidative damage at peripheral, spinal and supraspinal levels.
    Pathak NN; Balaganur V; Lingaraju MC; Kant V; Latief N; More AS; Kumar D; Kumar D; Tandan SK
    Neurochem Int; 2014 Mar; 68():1-9. PubMed ID: 24513038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Statin treatment upregulates vascular neuronal nitric oxide synthase through Akt/NF-kappaB pathway.
    Nakata S; Tsutsui M; Shimokawa H; Yamashita T; Tanimoto A; Tasaki H; Ozumi K; Sabanai K; Morishita T; Suda O; Hirano H; Sasaguri Y; Nakashima Y; Yanagihara N
    Arterioscler Thromb Vasc Biol; 2007 Jan; 27(1):92-8. PubMed ID: 17082483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antihyperalgesic and anti-inflammatory effects of atorvastatin in chronic constriction injury-induced neuropathic pain in rats.
    Pathak NN; Balaganur V; Lingaraju MC; More AS; Kant V; Kumar D; Kumar D; Tandan SK
    Inflammation; 2013 Dec; 36(6):1468-78. PubMed ID: 23872719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors upregulate inducible NO synthase expression and activity in vascular smooth muscle cells.
    Kolyada AY; Fedtsov A; Madias NE
    Hypertension; 2001 Nov; 38(5):1024-9. PubMed ID: 11711492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atorvastatin inhibition of cytokine-inducible nitric oxide synthase expression in native endothelial cells in situ.
    Wagner AH; Schwabe O; Hecker M
    Br J Pharmacol; 2002 May; 136(1):143-9. PubMed ID: 11976279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of eNOS, iNOS, and NF-kappaB in upregulation and activation of cyclooxygenase-2 and infarct size reduction by atorvastatin.
    Ye Y; Martinez JD; Perez-Polo RJ; Lin Y; Uretsky BF; Birnbaum Y
    Am J Physiol Heart Circ Physiol; 2008 Jul; 295(1):H343-51. PubMed ID: 18469150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term atorvastatin improves age-related endothelial dysfunction by ameliorating oxidative stress and normalizing eNOS/iNOS imbalance in rat aorta.
    Gong X; Ma Y; Ruan Y; Fu G; Wu S
    Exp Gerontol; 2014 Apr; 52():9-17. PubMed ID: 24463049
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced cardioprotection against ischemia-reperfusion injury with combining sildenafil with low-dose atorvastatin.
    Rosanio S; Ye Y; Atar S; Rahman AM; Freeberg SY; Huang MH; Uretsky BF; Birnbaum Y
    Cardiovasc Drugs Ther; 2006 Feb; 20(1):27-36. PubMed ID: 16435070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protective effects of statins involving both eNOS and tPA in focal cerebral ischemia.
    Asahi M; Huang Z; Thomas S; Yoshimura S; Sumii T; Mori T; Qiu J; Amin-Hanjani S; Huang PL; Liao JK; Lo EH; Moskowitz MA
    J Cereb Blood Flow Metab; 2005 Jun; 25(6):722-9. PubMed ID: 15716855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atorvastatin attenuates angiotensin II-induced inflammatory actions in the liver.
    Moreno M; Ramalho LN; Sancho-Bru P; Ruiz-Ortega M; Ramalho F; Abraldes JG; Colmenero J; Dominguez M; Egido J; Arroyo V; Ginès P; Bataller R
    Am J Physiol Gastrointest Liver Physiol; 2009 Feb; 296(2):G147-56. PubMed ID: 19056767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atorvastatin protects obese mice against hepatic ischemia-reperfusion injury by Toll-like receptor-4 suppression and endothelial nitric oxide synthase activation.
    Ajamieh H; Farrell G; Wong HJ; Yu J; Chu E; Chen J; Teoh N
    J Gastroenterol Hepatol; 2012 Aug; 27(8):1353-61. PubMed ID: 22432744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atorvastatin restores the impaired vascular endothelium-dependent relaxations mediated by nitric oxide and endothelium-derived hyperpolarizing factors but not hypotension in sepsis.
    Subramani J; Kathirvel K; Leo MD; Kuntamallappanavar G; Uttam Singh T; Mishra SK
    J Cardiovasc Pharmacol; 2009 Dec; 54(6):526-34. PubMed ID: 19755915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroprotective effect of saponin rich extract of Acorus calamus L. in rat model of chronic constriction injury (CCI) of sciatic nerve-induced neuropathic pain.
    Muthuraman A; Singh N
    J Ethnopharmacol; 2012 Aug; 142(3):723-31. PubMed ID: 22706151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atorvastatin prevents end-organ injury in salt-sensitive hypertension: role of eNOS and oxidant stress.
    Zhou MS; Jaimes EA; Raij L
    Hypertension; 2004 Aug; 44(2):186-90. PubMed ID: 15238570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atorvastatin ameliorates arsenic-induced hypertension and enhancement of vascular redox signaling in rats.
    Sarath TS; Waghe P; Gupta P; Choudhury S; Kannan K; Pillai AH; Harikumar SK; Mishra SK; Sarkar SN
    Toxicol Appl Pharmacol; 2014 Nov; 280(3):443-54. PubMed ID: 25218292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms underlying recoupling of eNOS by HMG-CoA reductase inhibition in a rat model of streptozotocin-induced diabetes mellitus.
    Wenzel P; Daiber A; Oelze M; Brandt M; Closs E; Xu J; Thum T; Bauersachs J; Ertl G; Zou MH; Förstermann U; Münzel T
    Atherosclerosis; 2008 May; 198(1):65-76. PubMed ID: 18061195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of long-term administration of HMG-CoA reductase inhibitor, atorvastatin, on stroke events and local cerebral blood flow in stroke-prone spontaneously hypertensive rats.
    Tanaka N; Katayama Y; Katsumata T; Otori T; Nishiyama Y
    Brain Res; 2007 Sep; 1169():125-32. PubMed ID: 17706949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.